Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-16”

189 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 189 results

Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Not applicableNot Yet RecruitingNCT07714577
What this trial is testing

Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

Who this might be right for
HPV16/18 Positive
Tianjin First Central Hospital 200
Early research (Phase 1)Study completedNCT00257738
What this trial is testing

0804 GCC: MAGE-A3/HPV 16 Vaccine for Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Maryland, Baltimore 17
Testing effectiveness (Phase 2)Ended earlyNCT03439085
What this trial is testing

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Who this might be right for
Human Papillomavirus-16 PositiveHuman Papillomavirus-18 PositiveMetastatic Malignant Neoplasm+18 more
M.D. Anderson Cancer Center 41
Early research (Phase 1)Ended earlyNCT03197025
What this trial is testing

Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions

Who this might be right for
Human PapillomavirusHPV-16High Grade Squamous Intraepithelial Lesion
National Cancer Institute (NCI) 1
Early research (Phase 1)UnknownNCT05122221
What this trial is testing

CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers

Who this might be right for
Cervical CancerAnal CancerHead and Neck Cancers
Corregene Biotechnology Co., Ltd 12
Testing effectiveness (Phase 2)UnknownNCT03669718
What this trial is testing

Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV16 Positive
ISA Pharmaceuticals 194
Not applicableStudy completedNCT01694875
What this trial is testing

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Who this might be right for
Human Papillomavirus Infection
Gen-Probe, Incorporated 2,200
Testing effectiveness (Phase 2)Study completedNCT00365378
What this trial is testing

Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)

Who this might be right for
HPV 16 Infection
Merck Sharp & Dohme LLC 2,409
Testing effectiveness (Phase 2)UnknownNCT04800978
What this trial is testing

Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
Samsung Medical Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07290621
What this trial is testing

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

Who this might be right for
Oropharyngeal Cancer
University of Chicago 30
Testing effectiveness (Phase 2)Study completedNCT04260126
What this trial is testing

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck CancerRecurrent Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
PDS Biotechnology Corp. 95
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Testing effectiveness (Phase 2)Study completedNCT00002916
What this trial is testing

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Who this might be right for
Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Not applicableUnknownNCT00662662
What this trial is testing

Sexual Behavior in Head and Neck Cancer Patients

Who this might be right for
Oropharyngeal CancerHead and Neck CancerSquamous Cell Carcinoma
M.D. Anderson Cancer Center 1,500
Early research (Phase 1)UnknownNCT03870113
What this trial is testing

DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2

Who this might be right for
Cervical Intraepithelial Neoplasia
Shenzhen People's Hospital 80
Not applicableStudy completedNCT01663259
What this trial is testing

Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV
University of Michigan Rogel Cancer Center 43
Post-approval studies (Phase 4)Looking for participantsNCT05334706
What this trial is testing

Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Who this might be right for
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) InfectionsHigh-risk HPV+1 more
Miquel Angel Pavon Ribas 69
Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Next Page